GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Marksans Pharma Ltd (NSE:MARKSANS) » Definitions » Days Sales Outstanding

Marksans Pharma (NSE:MARKSANS) Days Sales Outstanding : 69.98 (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Marksans Pharma Days Sales Outstanding?

Marksans Pharma's average Accounts Receivable for the three months ended in Dec. 2023 was ₹4,495 Mil. Marksans Pharma's Revenue for the three months ended in Dec. 2023 was ₹5,861 Mil. Hence, Marksans Pharma's Days Sales Outstanding for the three months ended in Dec. 2023 was 69.98.

The historical rank and industry rank for Marksans Pharma's Days Sales Outstanding or its related term are showing as below:

NSE:MARKSANS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 65.34   Med: 81.38   Max: 111.8
Current: 73.68

During the past 13 years, Marksans Pharma's highest Days Sales Outstanding was 111.80. The lowest was 65.34. And the median was 81.38.

NSE:MARKSANS's Days Sales Outstanding is ranked worse than
51.25% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 72.57 vs NSE:MARKSANS: 73.68

Marksans Pharma's Days Sales Outstanding declined from Dec. 2022 (77.18) to Dec. 2023 (69.98).


Marksans Pharma Days Sales Outstanding Historical Data

The historical data trend for Marksans Pharma's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marksans Pharma Days Sales Outstanding Chart

Marksans Pharma Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 65.34 67.86 68.73 82.21 80.08

Marksans Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 77.18 78.68 76.07 77.21 69.98

Competitive Comparison of Marksans Pharma's Days Sales Outstanding

For the Drug Manufacturers - General subindustry, Marksans Pharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Marksans Pharma's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Marksans Pharma's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Marksans Pharma's Days Sales Outstanding falls into.



Marksans Pharma Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Marksans Pharma's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

Days Sales Outstanding (A: Mar. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2022 ) + Accounts Receivable (A: Mar. 2023 )) / count ) / Revenue (A: Mar. 2023 )*Days in Period
=( (3947.78 + 4168.46) / 2 ) / 18496.19*365
=4058.12 / 18496.19*365
=80.08

Marksans Pharma's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (4495.18 + 0) / 1 ) / 5861.27*365 / 4
=4495.18 / 5861.27*365 / 4
=69.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Marksans Pharma  (NSE:MARKSANS) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Marksans Pharma Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Marksans Pharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Marksans Pharma (NSE:MARKSANS) Business Description

Traded in Other Exchanges
Address
Veera Desai Extension Road, 11th Floor, Grandeur, Opposite Gundecha Symphony, Oshiwara, Andheri (West), Mumbai, MH, IND, 400053
Marksans Pharma Ltd is a pharmaceutical company. The company is engaged in the research, manufacturing, and marketing of pharmaceutical formulations. It manufactures analgesics, gastroenterology, anti-diabetic, cardiovascular, pain management, gynecology, gastrointestinal and oncologic drugs as well as antibiotics and antiallergic medications. It has a market presence with the majority of the revenue generated from the United States and North America, followed by Europe and the UK, Australia and New Zealand, India, and the Rest of the World.

Marksans Pharma (NSE:MARKSANS) Headlines

No Headlines